Daphne Koller: Biomedicine and Machine Learning | Lex Fridman Podcast #93
Daphne Koller, Lex Fridman, Andrew Ng
Stanford professor and In-Citro CEO Daphne Kohler is bridging computer science and biomedicine by developing "disease-in-a-dish" models that use induced pluripotent stem cells and CRISPR to generate high-quality data for training machine learning algorithms. This strategy aims to uncover the heterogeneous biological mechanisms behind complex conditions like Alzheimer's and schizophrenia, moving beyond the limitations of traditional animal models to identify novel gene pathways and interventions. Drawing on her background co-founding Coursera, Kohler emphasizes that while artificial general intelligence remains distant, immediate progress relies on improving model uncertainty calibration and leveraging foundational mathematics to ensure AI applications in healthcare are both robust and ethically sound.